X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Risperdal. Risperdal. Photo: Housed via Wikimedia Commons

An attorney representing a man injured by the antipsychotic medication Risperdal painted the drugmaker Johnson & Johnson as a malicious company that pushed for the drug’s off-label use in children despite evidence linking the drug to excessive growth of breast tissue in boys and young men all in an effort to maximize profits over the safety of children.

“They have a target. They know who they want to make money from: kids. And not just any kids. Kids who are the most vulnerable in our society. Kids with autism and Asperger’s and ADD,” Houston lawyer Jason Itkin of Arnold & Itkin told the Philadelphia jury Tuesday morning.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Max Mitchell

Max Mitchell is ALM's Pennsylvania Bureau Chief overseeing The Legal Intelligencer, Delaware Law Weekly and Delaware Business Court Insider. Follow him on Twitter @MMitchellTLI. His email is [email protected]

More from this author

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.